Hematopoietic Neoplasm/Leukemia - Miscellaneous

NCT04387656

Clinical Trial Information

Trial Number: NCT04387656 (ClinicalTrials.gov)

Disease Type:

Hematopoietic Neoplasm/Leukemia - Miscellaneous
Miscellaneous Neoplasm - Solid Tumor

Trial Title:

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study

Study ID:

NCICOVID

Images are available?:

Is this a NCI-MATCH Trial?:

Datasets Linked to Trial

Title	Description
NCT04387656-D1	This dataset contains information used in the analyses described and presented in “COVID-19 severity by vaccination status in patients enrolled to the National Cancer Institute COVID-19 and Cancer Patients Study (NCCAPS)”, including the erratum. Data can be used to approximate published study findings, but exact reproduction of previous manuscripts may not be possible in some cases (e.g., when data must be modified for de-identification purposes or have undergone further data cleaning). Data presented in Figure 1 in the publication are not contained within this data submission, and data presented in Figure 2 have been modified due to de-identification procedures. Specifically, dates of study enrollment and first positive SARS-CoV-2 test have been omitted and year of first positive SARS-CoV-2 test has been substituted for time period of first positive SARS-CoV-2 test.

Title

Description

NCT04387656-D1

This dataset contains information used in the analyses described and presented in “COVID-19 severity by vaccination status in patients enrolled to the National Cancer Institute COVID-19 and Cancer Patients Study (NCCAPS)”, including the erratum.
Data can be used to approximate published study findings, but exact reproduction of previous manuscripts may not be possible in some cases (e.g., when data must be modified for de-identification purposes or have undergone further data cleaning). Data presented in Figure 1 in the publication are not contained within this data submission, and data presented in Figure 2 have been modified due to de-identification procedures. Specifically, dates of study enrollment and first positive SARS-CoV-2 test have been omitted and year of first positive SARS-CoV-2 test has been substituted for time period of first positive SARS-CoV-2 test.

NCT04439279

Clinical Trial Information

Trial Number: NCT04439279 (ClinicalTrials.gov)

Disease Type:

Hematopoietic Neoplasm/Leukemia - Miscellaneous
Miscellaneous Neoplasm - Solid Tumor

Trial Title:

MATCH Treatment Subprotocol R: Phase II Study of Trametinib in Patients With BRAF Fusions, or With NonV600E, Non-V600K BRAF Mutations

Study ID:

EAY131-R

Images are available?:

Is this a NCI-MATCH Trial?:

NCT01371656

Clinical Trial Information

Trial Number: NCT01371656 (ClinicalTrials.gov)

Disease Type:

Hematopoietic Neoplasm/Leukemia - Miscellaneous

Trial Title:

A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

Study ID:

ACCL0934

Images are available?:

Is this a NCI-MATCH Trial?:

Datasets Linked to Trial

Title	Description
NCT01371656-D6	There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D6 provides the information for chemotherapy groups (eTable 2). Data provided for all eligible Acute Myeloid or Acute Lymphoblastic Leukemia patients (N=381 entries or 198 patients). The number of rows per patient is dependent on number of chemotherapy cycles submitted.
NCT01371656-D5	There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D5 provides the information for susceptibility test results described in the manuscript (text only). Data limited to evaluable patients with susceptibility tests (N=136 entries). There are multiple rows per patient.
NCT01371656-D4	There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D4 provides the information for adverse events or serious adverse events during the infection observation period. Data limited to all evaluable patients with adverse events or serious adverse events (N=176 entries). The number of rows per patient is dependent on number of adverse events submitted.
NCT01371656-D3	There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D3 provides the musculoskeletal (MSK) information as reported in the manuscript (Table 3). Data limited to all evaluable patients with MSK data (N=1318 entries). There are multiple rows per patient.
NCT01371656-D2	There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D2 provides the information for baseline characteristics and all primary, secondary and post-hoc analyses as reported in the manuscript (Tables 1-5). Additionally, information regarding conditioning, GVHD prophylaxis and serotherapy as reported in the supplemental table of the manuscript can be found here as well (eTable 2). Data provided for all eligible patients (N=617) but the analysis is limited to all evaluable patients (N=613, INEVAL≠1). There is one row per patient.
NCT01371656-D1	There are six datasets associated with PubMed ID 30208456 (NCT01371656-D1 through -D6). NCT01371656-D1 provides the information for the consort diagram (Figure 1). Data provided on all enrolled patients (N=624). There is one row per patient.

Subscribe to Hematopoietic Neoplasm/Leukemia - Miscellaneous

Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security

U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov

NIH…Turning Discovery Into Health^®